Saturday September 19, 2020

Elan looks to nanotechnology for growth

During the Elan price collapse in February 2005, the internet investment boards were buzzing with an unusual angle to the story.

10th June, 2006

During the Elan price collapse in February 2005, the internet investment boards were buzzing with an unusual angle to the story. Investors were talking about a buying opportunity after the suspension of multiple scelerosis drug Tysabri, and were pointing to Elan’s leading role in nanotechnology for their enthusiasm.

Since then, the global buzz about nanotechnology has not abated and Elan has a world-leading position in the industry. Nanotechnology in the pharmaceutical industry is about...

Subscribe from just €1 for the first month!

Exclusive offers:

All Digital Access + eReader

Trial

€1

Unlimited Access for 1 Month

Then €19.99 a month after the offer period.

Get basic
*New subscribers only
You can cancel any time.

Annual

€200

€149 For the 1st Year

Unlimited Access for 1 Year

You can cancel any time.

Quarterly

€55

€42

90 Day Pass

You can cancel any time.

2 Yearly

€315

€248

Unlimited Access for 2 Years

This product does not auto-renew

Team Pass

Get a Business Account for you and your team

Share this post

Related Stories

The best writing and and the biggest stories of 2019 from the Business Post

Richie Oakley | 8 months ago

Denis O’Brien is back in court, residents continue to fight the Council on halting site and a row surfaces in government over rent control proposals

Leanna Byrne | 4 years ago